Moderna Says its Vaccine is Highly Effective in Preventing COVID-19
Summary from the AllSides News Team
Featured Coverage of this Story
From the Right
Moderna: Coronavirus vaccine nearly 95% effective in early lookModerna’s coronavirus vaccine was nearly 95% effective and thwarted severe disease in an interim analysis, the company said Monday, putting a second drugmaker on track to request emergency approval before the end of the year.
The Cambridge, Massachusetts, company said it counted 95 cases within its trial of 30,000 participants. Only five of them were in the vaccine arm of the trial, versus 90 in the placebo group.
It also looked at 11 severe cases of COVID-19 and found that all of those participants received the dummy shots, not the...
From the Left
Moderna's candidate COVID-19 vaccine looks to protect 94.5% of those who get it, trial shows. 'This makes me giddy,' one doctor says.A second COVID-19 candidate vaccine looks to be even more effective than the first, with both protecting more than 90% of those who get the shots.
Moderna, a Cambridge, Massachusetts-based biotechnology company, announced early Monday that its candidate vaccine, mRNA-1273, developed in collaboration with the U.S. government, appears to be 94.5% effective against the disease.
Earlier this month, Pfizer and its German partner BioNTech, announced early effectiveness data, showing their vaccine, called BNT162b2, had protected more than 90% of those who received it.
Both results are preliminary, with final...
From the Left
Moderna’s coronavirus vaccine found to be nearly 95 percent effective in a preliminary analysisBiotechnology firm Moderna announced Monday that a preliminary analysis shows its experimental coronavirus vaccine is nearly 95 percent effective at preventing illness, including severe cases — a striking initial result that leaves the United States with the prospect that two coronavirus vaccines could be available on a limited basis by the end of the year.
The news comes a week after pharmaceutical giant Pfizer and its German partner BioNTech lifted the stock market and people’s hopes with the news that their coronavirus vaccine was more than 90 percent effective.
Based...
AllSides Picks
May 17th, 2024
May 17th, 2024
May 16th, 2024